IP Library › Assignment 049689/0136
Patent Assignment
Reel/Frame 049689/0136

Merger and Change of Name

Recorded: 2019-01-24 Pages: 10
Assignors
SIGMA TAU RESEARCH SWITZERLAND SA
Executed: 2016-12-01
LEADIANT BIOSCIENCES SA
Executed: 2016-12-01
Assignee
LEADIANT BIOSCIENCES SA IN LIQUIDAZIONE
VIA MOTTA 2, MENDRISIO, 6850, ITALY
Covered Properties (2)
Derivatives of Partially Desulphated Glycosaminoglycans as Heparanase Inhibitors, Endowed with Antiangiogenic Activity and Devoid of Anticoagulating Effect
Patent: 7,781,416 →
Application: 11/314,736 →
Publication: US 2006/0172968
Derivatives of Partially Desulphated Glycosaminoglycans as Heparanase Inhibitors, Endowed with Antiangiogenic Activity and Devoid of Anticoagulating Effect
Patent: 8,067,555 →
Application: 11/882,978 →
Publication: US 2008/0051567
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 7, 2006
From: CASU, BENITO; TORRI, GIANGIACOMO; NAGGI, ANNA MARIA; PISANO, CLAUDIO
To: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
Reel/Frame 017770/0760 →
Assignment of Assignor's Interest Feb 13, 2008
From: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
To: SIGMA-TAU RESEARCH SWITZERLAND S.A.
Reel/Frame 020531/0898 →